| Kraig Biocraft Laboratories Launches Performance Yarn Development Program and Ships Spider Silk to Yarn and Aerospace Innovator |
Globe Newswire |
10/26 |
07:05 |
| HBT Financial, Inc. Announces Third Quarter 2026 Financial Results |
Globe Newswire |
10/26 |
07:05 |
| VETmAb Biosciences Announces Positive Clinical Proof-of-Concept Results for Long-Acting Anti-IL-23 Antibody in Canine Chronic Inflammatory Enteropathy |
Globe Newswire |
10/26 |
07:00 |
| GXO and Agility Robotics Expand Partnership to Accelerate Deployment of Humanoids in U.S. Operations |
Globe Newswire |
10/26 |
07:00 |
| Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis |
Globe Newswire |
10/26 |
07:00 |
| TILT Biotherapeutics Presents Encouraging Phase 1b Results in Ovarian Cancer at ESMO 2026 |
Globe Newswire |
10/26 |
07:00 |
| Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Lincoln Educational Services (LINC), FuelCell Energy, Inc. (FCEL), and AST SpaceMobile, Inc. (ASTS) Announced by Holzer & Holzer, LLC |
Globe Newswire |
10/26 |
07:00 |
| Syndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026 |
Globe Newswire |
10/26 |
07:00 |
| Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights |
Globe Newswire |
10/26 |
07:00 |
| AutoZone Chief Financial Officer Jamere Jackson to Depart November 25, 2026 |
Globe Newswire |
10/26 |
07:00 |
| Lakeland Financial Reports Record Third Quarter Performance with Loan Growth of 8%; Diluted Earnings per Share Increases by 11% |
Globe Newswire |
10/26 |
07:00 |
| Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting |
Globe Newswire |
10/26 |
07:00 |
| Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026 |
Globe Newswire |
10/26 |
07:00 |
| Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026 |
Globe Newswire |
10/26 |
07:00 |
| Nayax to Report 2026 Q3 Earnings on November 11, 2026 |
Globe Newswire |
10/26 |
07:00 |
| Verizon Delivers Another Record-Breaking Quarter with 3Q 2026 Results Driven by Strong Postpaid Phone and Account Additions |
Globe Newswire |
10/26 |
07:00 |
| Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparedness |
Globe Newswire |
10/26 |
07:00 |
| Centauri Minerals Inc. Begins Trading on OTCQX Best Market |
Globe Newswire |
10/26 |
07:00 |
| Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Tigo Energy, Inc. (TYGO), Fluence Energy, Inc. (FLNC), and Anavex Life Sciences Corp. (AVXL) Announced by Holzer & Holzer, LLC |
Globe Newswire |
10/26 |
07:00 |
| Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026 |
Globe Newswire |
10/26 |
07:00 |
| Fury Intersects 14.95 g/t Gold over 4.25 Metres at Eau Claire, Extending High-Grade Mineralization 60 Metres Up-Dip |
Globe Newswire |
10/26 |
06:59 |
| YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST |
Globe Newswire |
10/26 |
06:55 |
| InnoCare Reports 2026 Q3 Results, Sustained Profitability and Accelerating Globalization |
Globe Newswire |
10/26 |
06:42 |
| Sixthfin Financial Close Automation Software 2026: Close Review and Control Layer Targets the Gap Between Completing the Close and Reviewing Its Output in UK Multi-ERP Enterprises |
Globe Newswire |
10/26 |
06:38 |
| FasTreat Expands Virtual Mental Health Access in Canada, Reports More Than 28,000 Appointments |
Globe Newswire |
10/26 |
06:33 |
